Atrial fibrillation and stroke risk prevention in real-life clinical practice

被引：12
作者：
Tay, Kok Hoon [1 ]
Lip, Gregory Y. H. [1 ]
Lane, Deirdre A. [1 ]
机构：
[1] City Hosp, Univ Dept Med, Birmingham B18 7QH, W Midlands, England
来源：
THROMBOSIS AND HAEMOSTASIS | 2009年 / 101卷 / 03期
关键词：
ELDERLY-PATIENTS; WARFARIN; THROMBOPROPHYLAXIS; ANTICOAGULATION; STRATIFICATION; THROMBOEMBOLISM; POPULATION; THERAPY; CHOICE; DRUG;
D O I：
10.1160/TH08-10-0645
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：415 / 416
页数：2
相关论文
共 15 条
  • [1] Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation
    Fang, MC
    Chang, YC
    Hylek, EM
    Rosand, J
    Greenberg, SM
    Go, AS
    Singer, DE
    [J]. ANNALS OF INTERNAL MEDICINE, 2004, 141 (10) : 745 - 752
  • [2] Atrial fibrillation or flutter and stroke: a Danish population-based study of the effectiveness of oral anticoagulation in clinical practice
    Frost, L
    Johnsen, SP
    Pedersen, L
    Toft, E
    Husted, S
    Sorensen, HT
    [J]. JOURNAL OF INTERNAL MEDICINE, 2002, 252 (01) : 64 - 69
  • [3] Anticoagulation therapy for stroke prevention in atrial fibrillation - How well do randomized trials translate into clinical practice?
    Go, AS
    Hylek, EM
    Chang, YC
    Phillips, KA
    Henault, LE
    Capra, AM
    Jensvold, NG
    Selby, JV
    Singer, DE
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (20): : 2685 - 2692
  • [4] Comparison of 12 risk stratification schemes to predict stroke in patients with nonvalvular atrial fibrillation
    Hart, Robert G.
    Pearce, Lesly A.
    Halperin, Jonathan L.
    Hylek, Elaine M.
    Albers, Gregory W.
    Anderson, David C.
    Connolly, Stuart J.
    Friday, Gary H.
    Gage, Brian F.
    Go, Alan S.
    Goldstein, Larry B.
    Gronseth, Gary
    Lip, Gregory Y. H.
    Sherman, David G.
    Singer, Daniel E.
    van Walraven, Carl
    [J]. STROKE, 2008, 39 (06) : 1901 - 1910
  • [5] Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation
    Hart, Robert G.
    Pearce, Lesly A.
    Aguilar, Maria I.
    [J]. ANNALS OF INTERNAL MEDICINE, 2007, 146 (12) : 857 - 867
  • [6] Stroke and thromboembolism in atrial fibrillation: A systematic review of stroke risk factors, risk stratification schema and cost effectiveness data
    Hughes, Michael
    Lip, Gregory Y. H.
    [J]. THROMBOSIS AND HAEMOSTASIS, 2008, 99 (02) : 295 - 304
  • [7] Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'
    Hylek, Elaine M.
    [J]. THROMBOSIS AND HAEMOSTASIS, 2008, 100 (01) : 16 - 17
  • [8] Paroxysmal atrial fibrillation, stroke risk and thromboprophylaxis
    Lip, Gregory Y. H.
    [J]. THROMBOSIS AND HAEMOSTASIS, 2008, 100 (01) : 11 - 13
  • [9] Risk factors and stroke risk stratification for atrial fibrillation: Limitations and new possibilities
    Lip, Gregory Y. H.
    [J]. AMERICAN HEART JOURNAL, 2008, 156 (01) : 1 - 3
  • [10] Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial
    Mant, Jonathan
    Hobbs, F. D. Richard
    Fletcher, Kate
    Roalfe, Andrea
    Fitzmaurice, David
    Lip, Gregory Y. H.
    Murray, Ellen
    [J]. LANCET, 2007, 370 (9586) : 493 - 503
12